05/03/2024
6:01 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
3:18 PM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
NYSE AMERICAN LLC (Filed by)
| Form 25-NSE | |
04/18/2024
5:22 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Park Seongsoo (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/16/2024
8:09 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Daewoong Co., Ltd (Reporting)
| Form 4/A | |
04/12/2024
6:00 AM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Daewoong Co., Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:07 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form S-1/A | |
04/01/2024
4:27 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
|
03/29/2024
3:16 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
2:48 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 10-Q/A | |
03/29/2024
2:49 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/29/2024
2:46 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:06 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
5:39 AM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Daewoong Co., Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:43 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Wilson Alexander Blair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:45 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Carter Eric G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:46 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:48 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Oh Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:49 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Forth Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:51 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
PALMISANO ROBERT J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:52 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Thunen Shelley B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:33 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
12:46 PM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Polar Asset Management Partners Inc. (Filed by)
| Form SC 13G | |
11/22/2023
8:48 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form S-1/A | |
11/13/2023
8:01 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2023
8:00 AM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/20/2023
8:46 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form S-1/A | |
10/19/2023
3:23 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2023
4:06 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2023
3:37 PM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Strathspey Crown Holdings Group, LLC (Filed by)
| Form SC 13D/A | |
08/22/2023
3:31 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form DEL AM | |
08/18/2023
4:27 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
08/11/2023
8:12 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K/A | |
07/31/2023
5:39 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Strathspey Crown Holdings Group, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/31/2023
3:45 PM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Strathspey Crown Holdings Group, LLC (Filed by)
| Form SC 13D | |
07/31/2023
3:15 PM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
| Form SC 13G | |
07/31/2023
3:15 PM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Atalaya Capital Management LP (Filed by)
Atalaya Capital Management LP (Filed by)
| Form SC 13G | |
07/28/2023
6:54 AM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Daewoong Co., Ltd (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/28/2023
6:55 AM | AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Daewoong Co., Ltd (Filed by)
| Form SC 13D | |
07/27/2023
4:28 PM | AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2023
8:08 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Oh Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
8:09 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Carter Eric G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Dems have chosen Biden replacement? (Ad) On November 16, 2023…
Joe Biden accidentally revealed the name of the candidate…
Who will replace him in the 2024 presidential election. See who it is HERE. |
07/24/2023
8:10 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Wilson Alexander Blair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
7:59 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Forth Marc (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/24/2023
8:02 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Carter Eric G (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/24/2023
8:03 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Oh Chad (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/24/2023
8:03 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
REYNOLDS PETER A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/24/2023
8:04 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Wilson Alexander Blair (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/24/2023
8:04 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Thunen Shelley B (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/24/2023
8:05 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/24/2023
8:06 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
8:07 PM | AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Forth Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
5:43 AM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2023
2:40 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form CERT | |
07/21/2023
1:09 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities | |
07/21/2023
12:39 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 8-A12B | |
07/21/2023
10:44 AM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/20/2023
10:32 AM | Priveterra Acquisition Corp. (Subject)
Priveterra Acquisition Corp. (Subject)
AEON Biopharma (Subject)
Saba Capital Management, L.P. (Filed by)
| Form SC 13G/A | |
07/18/2023
4:10 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form S-4MEF | |
07/17/2023
4:18 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
4:19 PM | Priveterra Acquisition Corp. (Subject)
Priveterra Acquisition Corp. (Subject)
AEON Biopharma (Subject)
| Form 425 | |
07/05/2023
3:52 PM | Priveterra Acquisition Corp. (Subject)
Priveterra Acquisition Corp. (Subject)
AEON Biopharma (Subject)
| Form 425 | |
06/30/2023
7:26 AM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
7:27 AM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form DEFA14A | |
06/30/2023
7:29 AM | Priveterra Acquisition Corp. (Subject)
Priveterra Acquisition Corp. (Subject)
AEON Biopharma (Subject)
| Form 425 | |
06/29/2023
8:18 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
8:20 PM | Priveterra Acquisition Corp. (Subject)
Priveterra Acquisition Corp. (Subject)
AEON Biopharma (Subject)
| Form 425 | |
06/29/2023
8:25 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form DEFA14A | |
06/26/2023
3:07 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2023
3:11 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form DEFA14A | |
06/21/2023
3:11 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
3:13 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form DEFA14A | |
06/13/2023
3:47 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
3:49 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form DEFA14A | |
06/05/2023
8:33 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2023
8:36 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form DEFA14A | |
05/23/2023
8:38 PM | Priveterra Acquisition Corp. (Filer)
Priveterra Acquisition Corp. (Filer)
AEON Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2023
8:39 PM | Priveterra Acquisition Corp. (Subject)
Priveterra Acquisition Corp. (Subject)
AEON Biopharma (Subject)
| Form 425 | |
